Why the study?
Do Taurine and enzymatically modified isoquercitrin synergistically protect against methotrexate-induced cardiotoxicity in rats?
Do Taurine and enzymatically modified isoquercitrin synergistically protect against methotrexate-induced cardiotoxicity in rats?
The combination of taurine and enzymatically modified isoquercitrin synergistically mitigates methotrexate-induced cardiotoxicity in a rat model.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for MTX cardiotoxicity protection; does not support clinical use of taurine-EMIQ combination.
, induced DNA laddering and fragmentation, and increased cleaved caspase-3 protein expression in cardiac tissue. Both Tau and EMIQ showed equivalent effectiveness in protecting the heart against MTX-induced damage due to their antioxidant, anti-inflammatory, and antiapoptotic properties. Notably, combined treatment with half-doses of Tau and EMIQ offered superior protection compared to full doses of each agent alone. The full-dose combination showed similar efficacy to the half-dose combination, with a few exceptions. Overall, these results suggest a synergistic effect of Tau and EMIQ in mitigating MTX-induced cardiotoxicity, warranting further investigation into the underlying mechanisms.
No takes yet. Share an insight, caveat, or question.
Mahmoud et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: